Pfizer's (PFE) c.$12bn Zoetis, a Real Spinoff?
NEW YORK and LONDON, January 31, 2013 /PRNewswire/ --
"This is an IPO, not a Spinoff… Well not yet!" according to Ryan Mendy, COO of TSR, the UK based, leading global Spinoff and special situations research firm.
TSR's specialist analyst team have been looking at Pfizer's (PFE) various break-up potentials closely since 2010. Zoetis (ZTS), PFE's Animal Health business, is one of 120+ break-ups onTSR's 2013 calendar, but they believe the best is to come for investors.
"Zoetis is due to be priced today, valued at c.$12bn", comments Mendy. "Ourresearch sees a better investment angle on PFE if you want ZTS stock? Large investors are apparently oversubscribed to the IPO. There's still over two thirds [80%] of the company being held back by PFE management. Will they be distributed tax-free? Much better returns are generated fromSpinoffs than IPOs".
And the TSR team have a real edge, they returned +23% in FY2012 to funds using their research and they have a market leading history of both advising and delivering institutional clients solid benchmark outperforming returns from their fundamental analysis, weekly idea generation and recommendations on what future Spinoffs and Distressed Equity Situations will perform best(?). You can click here to see TSR's 5 year track record vs. major benchmarks.
PFE, valued at $197bn, are merely selling (raising money) for 20% of ZTS and holding back the rest to see how it performs, thus with no current tax-free distribution of the other 80% of stock back to current PFE shareholders, this is a pure IPO, not a Spinoff.
It appears Compuware (CPWR) is aiming to carry out a similar process now, just like Sunoco (SUN) did with its coke-making business SunCoke Energy (SXC) and Dean Foods (DF) is planning with its consumer segment, WhiteWave (WWAV).
How to get more?
Activism, Bankruptcy, Carve Outs, Deep Value, Catalysts, Demutualizations, Directors Dealings, Distressed Securities, Liquidations, Merger Securities, Mergers & Acquisitions, Post-Re-Orgs, Privatizations, Recapitalizations, Recovery Situations, Equity Restructurings, Reverse Mergers, Reverse Morris Trusts, Rights Offerings, Special Dividends, Spinoffs, Split-offs, Tender Offers and Turnarounds.
SOURCE The Spinoff Report Ltd
More by this Source
Breaking: S&P500 Research Reveals Stocks to Spinoff Businesses
17 Apr, 2013, 16:44 BST
Down -40%, Deep Value European Special Situations & Spinoff Stocks
09 Apr, 2013, 15:34 BST
Unknown Spinoff Stock Surges +70% After Being Added to The Spinoff Report Conviction Buy List
04 Apr, 2013, 05:00 BST
Journalists and Bloggers
Visit PR Newswire for Journalists for releases, photos and customised feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
Until you hear the full story, why would you invest?
Making sound investment decisions can be difficult. You can study the figures and read the analyst recommendations, but how do you really know the story behind company strategy? How can you get answers to your questions?
The Private Investor Network helps you to reach an informed decision on the stocks you pick. Interactive presentations from UK listed companies give you the kind of access previously enjoyed only by the big fund managers. And with keynote speeches from industry experts, downloadable content and an investor lounge where you can swap tips with your peers, you can invest with confidence.
For more information, and to register for FREE, visit us at www.privateinvestornetwork.co.uk
Get content for your website
Enhance your website's or blog's content with PR Newswire's customised real-time news feeds.
Contact PR Newswire
Send us an email at MarketingUK@prnewswire.co.uk or call us at +44 (0)20 7454 5382
Become a PR Newswire client
Request more information about PR Newswire products & services or call us at +44 (0)20 7454 5382